TETRAGENETICS PARTNERS W/ TOP 10 PHARMACEUTICAL CO.

 
FREE EXCERPT

TetraGenetics Inc. has formed another new partnership with one of the world's top ten pharmaceutical companies. This will be TetraGenetics' fifth program launched with either a large pharmaceutical and/or biotech partner for ion channel drug discovery.

The program utilizes TetraGenetics' unique and proprietary ion channel production capabilities for the discovery of novel therapeutics targeting sodium channels for pain management. This particular program will begin immediately.

TetraGenetics' CEO, Doug Kahn said We chose to focus on ion channels several years ago due to their importance in therapeutic drug discovery and the limited availability of high quality material required to launch effective programs. This new partnership reinforces the value of...

To continue reading

FREE SIGN UP